COLLEGIUM PHARMACEUTICAL, INC — Form 8-K
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 2/100
What the filing says
Collegium Pharmaceutical filed an 8-K on August 13, 2026 reporting other events as of August 12, 2026. The filing contains no narrative disclosure of specific business developments, transactions, counterparties, dollar amounts, or material changes — only standard SEC filing metadata and XBRL formatting documents. The substance of what 'other event' is being reported is not provided in the text.
Why this rating
No substantive business event disclosed; routine SEC procedural filing with no material fact communicated.
Extracted items
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.